Who is sponsoring NCT02057367?

NCT02057367 is sponsored by Chiang Mai University.

What condition does NCT02057367 study?

NCT02057367 studies Brain Tumour.

What drugs are being tested in NCT02057367?

Interventions: Scalp block with 0.5% plain Marcaine, Scalp block with 0.9% normal saline.

What is the status of NCT02057367?

NCT02057367 is currently COMPLETED.

Last reviewed 2016-07-25 · How we verify

The Effect of Pre-incisional Anterior Scalp Block on Intraoperative Opioid Consumption in Adult Patients Undergoing Elective Craniotomy to Remove Tumor: A Prospective Randomized Controlled

NCT02057367 Phase 4 COMPLETED

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

Details

Lead sponsor	Chiang Mai University
Phase	Phase 4
Status	COMPLETED
Enrolment	100
Start date	2013-03
Completion	2016-04

Conditions

Brain Tumour

Interventions

Scalp block with 0.5% plain Marcaine
Scalp block with 0.9% normal saline

Primary outcomes

Intraoperative opioid consumption — During the supratentorial craniotomy surgery
The overall intravenous fentanyl consumption (microgram/ kilogram) during the surgery. The decision to administer fentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.

Countries

Thailand